Comparative Effectiveness Research Translation Network

Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX, the sole API in KP1077, in Healthy Volunteers at Psych Congress 2023

Retrieved on: 
Sunday, September 10, 2023
Psych, Idiopathic hypersomnia, Doctor of Philosophy, Safety, API, IH, Drug, Research, Zebra, Congress, Comparative Effectiveness Research Translation Network, Methylphenidate, Vital signs, Somnolence, Poster, SDX, Therapy, Sleep, Disease, Pharmaceutical industry, Pharmacokinetics

In addition, both doses of SDX were generally better tolerated compared to Ritalin and fewer subjects experienced cardiovascular adverse events after SDX compared to Ritalin.

Key Points: 
  • In addition, both doses of SDX were generally better tolerated compared to Ritalin and fewer subjects experienced cardiovascular adverse events after SDX compared to Ritalin.
  • Lastly, vital signs after a single oral dose of 200 mg SDX (the highest dose tested) were comparable to Ritalin IR 80 mg and Ritalin LA 80 mg.
  • The results demonstrate a robust safety profile for SDX, positioning it as a promising option for treating sleep disorders characterized by excessive daytime sleepiness.
  • Details of Zevra’s poster presentation are as follows:
    Sr. Vice President of Clinical Development, Zevra Therapeutics

U.S. Dermatology Partners Honored with Comparably's Best Leadership Teams Award

Retrieved on: 
Thursday, August 3, 2023
Organization, Dermatology, Health, Comparative Effectiveness Research Translation Network, Culture, Management

DALLAS, Aug. 3, 2023 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners, one of the premier dermatology practices in the country, announced today that the organization has been recognized with Comparably's 2023 Best Leadership Teams award.

Key Points: 
  • DALLAS, Aug. 3, 2023 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners , one of the premier dermatology practices in the country, announced today that the organization has been recognized with Comparably's 2023 Best Leadership Teams award.
  • Comparably's annual Best Leadership Teams award is derived from millions of anonymous employee ratings on executive leadership teams and direct managers on Comparably.com over a 12-month period (May 2022 through May 2023).
  • "U.S. Dermatology Partners is privileged to have exceptional physician and business leadership teams that enable us to deliver exceptional patient care experiences, while also fostering a culture that our organization can be proud of," said Paul Singh, Chief Executive Officer at U.S. Dermatology Partners.
  • To view the complete list of winners of the Leadership Teams Award, please visit: https://www.comparably.com/awards/winners/best-leadership-teams-2023-large

Barracuda honored by Comparably for Best Leadership Teams and Best CEO for Diversity

Retrieved on: 
Wednesday, June 14, 2023
Workplace, HR, Interface (computing), Growth, Barracuda, Diversity, General counsel, Comparative Effectiveness Research Translation Network, Management

CAMPBELL, Calif., June 14, 2023 /PRNewswire/ -- Barracuda Networks, Inc., a trusted partner and leading provider for cloud-first security solutions today announced it has been again honored by Comparably with two awards, one for the best leadership teams and one for the best CEOs for diversity. Barracuda ranked 86 for this year's Best Leadership Teams award, which is based on how employees rate and approve of the job their worldwide leadership team is doing. In addition, Barracuda ranked 96 for this year's Best CEOs for Diversity award, which represents the top-ranked CEOs, based solely on anonymous sentiment ratings from employees of color on Comparably.com in the previous 12 months.

Key Points: 
  • Barracuda ranked 86 for this year's Best Leadership Teams award , which is based on how employees rate and approve of the job their worldwide leadership team is doing.
  • In addition, Barracuda ranked 96 for this year's Best CEOs for Diversity award , which represents the top-ranked CEOs, based solely on anonymous sentiment ratings from employees of color on Comparably.com in the previous 12 months.
  • "I want to express my gratitude to all our employees who embrace diversity and contribute to the inclusive culture we have at Barracuda," said Hatem Naguib, CEO at Barracuda.
  • Together, we have created a workplace that celebrates differences and leverages them to build an incredible culture at Barracuda."

Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
Wednesday, April 26, 2023
Surgery, Medical Devices, Health, Pharmaceutical, Optical, Tradition, Intraocular lens, Aperture, ASCRS, Astigmatism, Pain, Employment, Telecanthus, Incidence, Patient, Outcome, Viral, Steroid, Herpes simplex, NYSE, Chickenpox, Very-small-aperture terminal, Conjunctiva, Cornea, Comparative Effectiveness Research Translation Network, SM, Optic nerve, Cataract, FDA, Emerging technologies, Fungal infection, Refractive surgery, Use, Sclera, Eye, Bausch, History, Thought, American Society of Cataract and Refractive Surgery, Slit lamp, ARMOR, Glaucoma, DED, IOP, Contact lens, Infection, OVD, Inflammation, Vaccinia, Bausch & Lomb, Range, Convention (norm), Visual acuity, Society, Pharmaceutical industry, Telescopic sight, Telescope, Wood drying, Dentistry, Hospital, Retail, Veterinary medicine, Fused quartz, Vaccine, Dietary supplement, Emmetropia, Refraction, IOL

The posters and presentations include two studies assessing the new StableVisc™ cohesive ophthalmic viscosurgical device, which Bausch + Lomb commercially launched this month.

Key Points: 
  • The posters and presentations include two studies assessing the new StableVisc™ cohesive ophthalmic viscosurgical device, which Bausch + Lomb commercially launched this month.
  • Others include a retrospective chart review on the use of LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% in refractive surgery and numerous presentations focused on Bausch + Lomb surgical IOL pipeline programs.
  • New data from the Bausch + Lomb Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study will also be presented.
  • “Clinical Evaluation of the Outcomes of Two Preloaded Monofocal IOLs Implanted Bilaterally in Cataract Patients.” Shultz et al.

Logically's Chief People Officer Receives CompTIA Diversity in Leadership Award

Retrieved on: 
Wednesday, March 15, 2023
AMA Foundation Leadership Award, SIA, Comparative Effectiveness Research Translation Network, Security Industry Association, Woman, Belgrade Security Forum, MSSP, Female, Parity, CompTIA, Logic, DEI, Joe Dey Award, Leading, Nursing

DUBLIN, Ohio, March 15, 2023 /PRNewswire/ -- Logically, one of the nation's leading managed IT and security service providers, today announced that the Computing Technology Industry Association (CompTIA) has recognized Dominique Andrews, Chief People Officer at Logically, in their annual 2023 North America Spotlight Awards. Andrews was awarded the "Advancing Diversity in Leadership Award", which honors innovators in the IT industry for their impact as advocates and role models in leading others with diversity, equity, and inclusion (DEI).

Key Points: 
  • Andrews was awarded the "Advancing Diversity in Leadership Award", which honors innovators in the IT industry for their impact as advocates and role models in leading others with diversity, equity, and inclusion (DEI).
  • This award marks Logically's third DEI recognition in recent months and showcases the company's strong focus on diversity.
  • In December 2022, Logically was recognized among the "Best Companies for Women" by Comparably , an award based on feedback from female employees.
  • CompTIA's North America Spotlight Awards are presented annually to individuals who demonstrate leadership in the IT industry across six different categories.

Startek Offers Mental Health Support App to New Mothers as Part of Diversity, Equity and Inclusion Initiatives

Retrieved on: 
Wednesday, March 8, 2023
Mental Health, Apps, Applications, Technology, Women, Human Resources, Baby, Maternity, Professional Services, DEI (Diversity, Equity and Inclusion), Consumer, Health, Depression, NYSE, Pregnancy, Equity, Workplace, Woman, International, Mother, Therapy, Partnership, Risk, SM, Mental health, Anxiety, Comparative Effectiveness Research Translation Network, CDC, CX, Sleep, Nursing, Birth control, Curio

Startek® (NYSE: SRT), a global customer experience (CX) solutions provider, today announced that it has partnered with Curio Digital Therapeutics to offer postpartum mental health support for its U.S.-based associates as part of its ongoing initiatives designed to promote diversity, equity and inclusion.

Key Points: 
  • Startek® (NYSE: SRT), a global customer experience (CX) solutions provider, today announced that it has partnered with Curio Digital Therapeutics to offer postpartum mental health support for its U.S.-based associates as part of its ongoing initiatives designed to promote diversity, equity and inclusion.
  • “This International Women’s Day, we recognize the role that technology can play in creating a more equitable workplace by supporting working mothers to navigate an extremely important time in their lives,” said SM Gupta, Chief People Officer, Startek.
  • “Sadly, postpartum depression can lead women to leave the workplace.
  • ”We are delighted to bring the MamaLift program to Startek employees through this partnership,” said Shailja Dixit, CEO, Curio Digital Therapeutics.

ChenMed Receives Two Prestigious Culture Awards: Best Companies for Women and Best Companies for Diversity

Retrieved on: 
Thursday, December 29, 2022
Computerworld, Organization, Work, Female, Patient, Education, Juneteenth, Trust, 100 Best Companies to Work For, Minority group, Trial balance, Health, Love, Black History Month, The Last Best Place, Medicare, All, Erg, Human sexuality, Change the World, Workforce, Multimedia, IDG, Newsweek, Member, Chenming Paper, Diversity, Culture, Physician, Software as a service, Individual, SMB, Comparative Effectiveness Research Translation Network, Women's History Month, ZoomInfo, VET, Health insurance, Medicine, Woman

MIAMI, Dec. 29, 2022 /PRNewswire/ -- ChenMed, a leading medical practice providing high-touch, personalized primary care to Medicare-eligible seniors, has received two coveted awards for the culture of love and inspiration it shows to its employees. The brand reputation platform, Comparably, has named ChenMed among the 2022 Best Companies for Women and Best Companies for Minorities. ChenMed is one of the few healthcare providers named to both lists.

Key Points: 
  • The brand reputation platform, Comparably, has named ChenMed among the 2022 Best Companies for Women and Best Companies for Minorities.
  • Those workplace culture awards - part of Comparably's annual Best Places to Work series – are based upon sentiment ratings provided by employees who anonymously responded to questions on Comparably.com.
  • Female employees offered ratings for the Women's list, while people of color provided ratings for the Diversity list.
  • For more information on Comparably's studies and annual Best Places to Work & Best Brands Awards, visit www.comparably.com/news
    View original content to download multimedia: https://www.prnewswire.com/news-releases/chenmed-receives-two-prestigiou...

AppliedVR Wins Q4 Comparably Awards in All Four Categories, Including Best Culture, Best CEO, Best Company for Women, and Best Company for Diversity.

Retrieved on: 
Tuesday, December 20, 2022
Patient, LOS, ITX, Medicine, FDA, Workforce, VR, Therapy, Pain, Culture, Diversity, Research, Comparative Effectiveness Research Translation Network, Pharmaceutical industry, Woman

LOS ANGELES, Dec. 20, 2022 /PRNewswire/ -- AppliedVR, an immersive therapeutics pioneer advancing a novel approach to medicine, announced it won four awards for its outstanding company culture and support for its workforce for the second time this year, awarded by Comparably.

Key Points: 
  • Comparably Awards are derived from sentiment ratings anonymously provided by employees about their workplaces in multiple categories during a 12-month period.
  • Out of 100 companies awarded in each category, AppliedVR ranked #26 for Best Company Culture, #32 for Best CEO, #70 for Best Company for Women, and #57 in Best Company for Diversity for small to mid-sized companies.
  • Previously, in October 2022, Applied VR took home Comparably awards for Happiest Employees, Best Compensation, Best Work-Life Balance, and Best Perks & Benefits.
  • AppliedVR is leading a new category of medicine that addresses a variety of indications through virtual reality-based therapeutics.

Viz.ai Wins Four Comparably Awards for Best Place to Work

Retrieved on: 
Thursday, December 15, 2022
Health, Technology, Health Technology, Practice Management, General Health, Artificial Intelligence, Life, Diversity, Diagnosis, BorgWarner, Data, Workplace, Hospital, Intelligence, Algorithm, Critical care, Multimedia, Machine learning, Comparative Effectiveness Research Translation Network, Disease, AI, Patient, Management, Medical device

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022.

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022.
  • Earlier this year, the Company was also awarded Best Company Outlook and Best Company Career Growth, bringing its total to four Comparably awards.
  • I would like to extend my deepest gratitude to those who participated in the Comparably ratings.
  • Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period.

Suki Closes Out 2022 with Significant Growth and Strong ROI Outcomes

Retrieved on: 
Wednesday, December 14, 2022
Technology, Nursing, Hospitals, Health Technology, Telemedicine, Virtual Medicine, Audio, Video, Other Health, Managed Care, Health, Artificial Intelligence, Vital signs, Physician, Hotwire, Human, Freedom, Jim Breyer, SSP, Venrock, Hospital, Natural language processing, Medicine, Allergy, Growth, Business intelligence, Documentation, MIC, Comparative Effectiveness Research Translation Network, Machine learning, Acquisition, Pharmaceutical industry, Chairish

Since January 2022, Sukis achievements spanned every area of business, from customer acquisition and operations to product development and rollout.

Key Points: 
  • Since January 2022, Sukis achievements spanned every area of business, from customer acquisition and operations to product development and rollout.
  • Using Suki Voice Assistant provided the margin Dr. Goff needed to stay in medicine full-time, an important outcome considering the clinician staffing shortages nationwide.
  • ROI outcomes: Sukis strong customer expansion is poised to continue into 2023, primarily driven by its ability to help health systems and provider groups to capture additional revenue.
  • At a time when more than half of health systems and hospitals are expected to lose money , Suki Assistant provides an avenue for substantial financial growth.